Putnam Investments LLC Abbott Laboratories Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

A detailed history of Putnam Investments LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Putnam Investments LLC holds 478,343 shares of ABT stock, worth $55.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

478,343

Previous 4,191,277 88.59%

Holding current value

$55.8 Million

Previous $406 Million 87.03%

% of portfolio

0.07%

Previous 0.64%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $335 Million - $410 Million	-3,712,934 Reduced 88.59%	478,343 $52.7 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $6.38 Million - $7.65 Million	-66,780 Reduced 1.57%	4,191,277 $406 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $3.2 Million - $3.56 Million	-31,748 Reduced 0.74%	4,258,057 $464 Million
Q1 2023 May 22, 2023	BUY	$96.86 - $114.01 $6.14 Million - $7.23 Million	63,394 Added 1.5%	4,289,805 $434 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $22.8 Million - $26.7 Million	-239,664 Reduced 5.37%	4,226,411 $464 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $99.8 Million - $116 Million	1,031,013 Added 30.01%	4,466,075 $432 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $239 Million - $289 Million	2,346,114 Added 215.45%	3,435,062 $373 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $3.04 Million - $3.71 Million	-26,690 Reduced 2.39%	1,088,948 $129 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $18 Million - $22 Million	155,844 Added 16.24%	1,115,638 $157 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $6.91 Million - $7.64 Million	59,195 Added 6.57%	959,794 $113 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $11.6 Million - $13.6 Million	109,493 Added 13.84%	900,599 $104 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $2.04 Million - $2.4 Million	18,735 Added 2.43%	791,106 $94.8 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $605,850 - $660,203	-5,770 Reduced 0.74%	772,371 $84.6 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $1.48 Million - $1.8 Million	16,169 Added 2.12%	778,141 $84.7 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $22.2 Million - $28.4 Million	-289,343 Reduced 27.52%	761,972 $69.7 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $13.1 Million - $19.2 Million	-208,819 Reduced 16.57%	1,051,315 $83 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $21.2 Million - $23.6 Million	-270,291 Reduced 17.66%	1,260,134 $109 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $22.2 Million - $24.1 Million	271,534 Added 21.57%	1,530,425 $128 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $4.75 Million - $5.54 Million	65,203 Added 5.46%	1,258,891 $106 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $77.9 Million - $94.2 Million	1,176,500 Added 6844.89%	1,193,688 $95.4 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $165,407 - $187,383	-2,523 Reduced 12.8%	17,188 $1.24 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $2,675 - $3,227	-44 Reduced 0.22%	19,711 $1.45 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $140,067 - $154,592	-2,433 Reduced 10.97%	19,755 $1.21 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $42,934 - $48,542	-763 Reduced 3.32%	22,188 $1.33 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $468,196 - $501,253	-8,722 Reduced 27.54%	22,951 $1.31 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $1.52 Million - $1.7 Million	31,673	31,673 $1.69 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.35B

Call Options Held

8.62M

Put Options Held

7.18M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $204B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account

Putnam Investments LLC Abbott Laboratories Transaction History